A Phase I Study of JLM019 Injection

Clinical trial NCT07623850 · RECRUITING

Trial details

NCT number: NCT07623850
Sponsor: Jecho Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor (Phase 1)Hodgkin Lymphoma Non-Hodgkin Lymphoma

Start date: 2026-01-13
Primary completion: 2029-03-14
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.